Compassionate Certification Centers™, a medical cannabis healthcare network, in partnership with Affinity Bio Partners, was recently selected by SciCann Therapeutics and FSD Pharma to launch the first clinical research study on Irritable Bowel Syndrome (IBS) in Pittsburgh, Pennsylvania.
Compassionate Certification Centers provides CBD and medical cannabis evaluations and certifications at its eight offices across Western Pennsylvania. The progressive healthcare network recently launched its own line of THC-free CBD products, available to patients and non-cardholders.
Leave a Reply